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Campylobacter jejuni is the most prevalent cause of food-borne gastroenteritis in the developed world; however, the molecular
basisofpathogenesisisunclear.Secretionofvirulencefactorsisakeymechanismbywhichentericbacterialpathogensinteract
with host cells to enhance survival and/or damage the host. However, C. jejuni lacks the virulence-associated secretion systems
possessedbyotherentericpathogens.Manybacterialpathogensutilizeoutermembranevesicles(OMVs)fordeliveryofviru-
lencefactorsintohostcells.Intheabsenceofprototypicalvirulence-associatedsecretionsystems,OMVscouldbeanimportant
alternative for the coordinated delivery of C. jejuni proteins into host cells. Proteomic analysis of C. jejuni 11168H OMVs iden-
tiﬁed151proteins,includingperiplasmicandoutermembrane-associatedproteins,butalsomanydeterminantsknowntobe
important in survival and pathogenesis, including the cytolethal distending toxin (CDT). C. jejuni OMVs contained 16 N-linked
glycoproteins,indicatingadeliverymechanismbywhichtheseperiplasm-locatedyetimmunogenicglycoproteinscaninteract
with host cells. C. jejuni OMVs possess cytotoxic activity and induce a host immune response from T84 intestinal epithelial cells
(IECs),whichwasnotreducedbyOMVpretreatmentwithproteinaseKorpolymyxinBpriortocoincubationwithIECs.Pre-
treatmentofIECswithmethyl-beta-cyclodextrinpartiallyblocksOMV-inducedhostimmuneresponses,indicatingarolefor
lipid rafts in host cell plasma membranes during interactions with C. jejuni OMVs. OMVs isolated from a C. jejuni 11168H cdtA
mutantinducedinterleukin-8(IL-8)tothesameextentasdidwild-typeOMVs,suggestingOMVinductionofIL-8isindepen-
dentofCDT.
C
ampylobacter jejuni is a Gram-negative, ﬂagellated bacterium
that is the leading causative agent of food-borne bacterial
acute human gastroenteritis worldwide (2). Symptoms range
frommilddiarrheatosevereinﬂammatoryenteritis.Themajority
of C. jejuni infections result in uncomplicated acute gastroenteri-
tis; however, C. jejuni is also the most commonly identiﬁed infec-
tiousagentinperipheralneuropathiessuchasGuillain-Barrésyn-
drome (GBS) (57). In the developing world, C. jejuni is a leading
causeofmortalityamongyoungchildren.IntheUnitedKingdom,
it is estimated that 500,000 C. jejuni infections occur each year
(34). C. jejuni is one of the most extensively characterized enteric
bacterialpathogensatthegeneticandphenotypiclevels;however,
in contrast to most other enteropathogens, the mechanisms by
whichC.jejunicausesdiarrhealdiseaseinhumansremainunclear
(18, 74). The genome content of C. jejuni strains appears anoma-
lous compared to most Gram-negative pathogens, having no
readily identiﬁable secretion systems to deliver virulence factors
into host cells. Clearly, alternative infection mechanisms need to
be investigated for this atypical enteropathogen.
The coordinated delivery of virulence factors is a common
mechanism by which enteric bacterial pathogens interact with
host cells to enhance their survival and/or cause damage to the
host cell. Secretion mechanisms utilized by enteric pathogens of-
ten require intimate contact with the host cell, such as the type III
andtypeIVsecretionsystems,whichdeliverbacterialproteinsand
nonprotein material (e.g., fragments of peptidoglycan) directly
into the host cytoplasm. Surprisingly, C. jejuni lacks many of the
virulence-associated secretion systems possessed by other enteric
pathogens. The only potential type III secretion system identiﬁed
in C. jejuni is the ﬂagellar apparatus (60). Previous studies have
indicated that the secretion of Campylobacter invasion antigens
(Cia) and other virulence factors is dependent on a functional
ﬂagellar apparatus (43, 62). However, the secretion of virulence
factorsviatheC.jejuniﬂagellariscontentious(58)andwouldnot
facilitatethedirectdeliveryofbacterialproteinsintohostcellsasis
observed with other enteric pathogens.
Rather than secrete virulence factors into the surrounding mi-
lieu,wheretheycouldbedegradedbyhostproteases,manyGram-
negative bacterial pathogens utilize outer membrane vesicles
(OMVs) as a mechanism of delivering active proteins and other
moieties into host cells (19). In this way, virulence factors are not
secreted individually but as multiple factors delivered in a con-
certed package. OMVs play roles in establishing colonization of
the host, delivering virulence factors and modulating the host re-
sponses for many Gram-negative bacterial pathogens (47). In-
deed, toxin delivery mediated by OMVs is recognized as a potent
virulence mechanism for many bacterial pathogens (19).
Both nonpathogenic and pathogenic Gram-negative bacteria
constitutively release OMVs (46). Bacterial OMVs are discrete,
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 closedoutermembraneblebsproducedbygrowingcellsandnota
productofcelllysisorcelldeath(46).OMVsaresphericalproteo-
liposomes with an average diameter ranging from 10 to 500 nm
(46). These nanostructures are enriched with outer membrane
proteins, phospholipids, lipooligosaccharides (LOS), and numer-
ous periplasmic proteins of wide molecular mass range (54).
Many virulence factors that are periplasmic proteins are enriched
inOMVs,includingenterotoxigenicEscherichiacoli(ETEC)heat-
labile enterotoxin (LT) (39). Recently, studies have reported a
diverse range of Gram-negative bacterial pathogens that readily
release various quantities of OMVs into their extracellular milieu
andforwhichOMVshavebeenassociatedwithpathogenesis(19).
Forexample,PseudomonasaeruginosaOMVshavebeenshownto
delivermultiplevirulencefactors,including-lactamase,alkaline
phosphatase, hemolytic phospholipase C, and the Cif toxin, di-
rectly into airway epithelial cells (10). The human oral pathogen
Porphyromonas gingivalis selectively sorts the gingipain proteases,
major virulence factors, into OMVs and excludes other abundant
outer membrane proteins (28).
Although OMVs from C. jejuni were identiﬁed nearly 30 years
ago (8, 52), it is only recently that the biological signiﬁcance of
OMV formation in C. jejuni pathogenesis has become apparent
with the discovery that biologically active cytolethal distending
toxin (CDT) is released within OMVs produced by C. jejuni 81-
176(49).ThiswastheﬁrstevidencethatC.jejuniutilizesOMVsto
delivervirulencefactorstothesurroundingenvironment,includ-
ing infected host tissue (49). Bacterial CDTs belong to the AB2-
type toxins and generally comprise three subunits, CdtA, CdtB,
and CdtC (24). CdtA and CdtC act as carriers to deliver the cata-
lyticsubunit,CdtB,intohostcells(67).CdtBexhibitsDNaseI-like
activity and induces limited DNA damage such as double-strand
damage,leadingtotheactivationofDNArepairresponsesandcell
cycle arrest at the G2/M phase (48, 73). C. jejuni CDT exerts mul-
tiple effects, including the release of interleukin-8 (IL-8) from
intestinal epithelial cells (IECs) (30, 76), promoting host DNA
repair responses (27), gastroenteritis in NF-B-deﬁcient mice
(21), and cell death in human monocytic cells (31).
Wehypothesizedthatintheabsenceofprototypicalvirulence-
associated secretion systems, C. jejuni utilizes OMVs to deliver
bacterial proteins to promote cellular adhesion and invasion,
while modulating the host response during infection of the hu-
man intestinal tract. This study used proteomic techniques to
identify C. jejuni OMV proteins and also investigated the interac-
tions of C. jejuni OMVs with IECs, including the role of OMV-
associated CDT in inducing the host innate immune response.
MATERIALS AND METHODS
Bacterial strains and culture conditions. The C. jejuni wild-type strains
used were strain 11168H, a hypermotile derivative of the sequence strain
NCTC11168, which shows higher levels of cecal colonization in a chick
colonizationmodel(35),andstrain81-176,agastroenteritisisolatewidely
used for C. jejuni infection studies (7). The C. jejuni 11168H pglB, peb3,
and cdtA mutants were obtained from the London School of Hygiene &
Tropical Medicine (LSHTM) Campylobacter Resource Facility (http://crf
.lshtm.ac.uk/index.htm). The mutations were conﬁrmed by PCR and se-
quencing as described previously (26). C. jejuni strains were grown either
onbloodagarplatescontainingColumbiaagarbase(Oxoid,Basingstoke,
United Kingdom) supplemented with 7% (vol/vol) horse blood (TCS
Microbiology, Botolph Claydon, United Kingdom) and Campylobacter
selectivesupplement(Oxoid)orinBrucellabroth(Oxoid)withshakingat
75 rpm at 37°C in a microaerobic chamber (Don Whitley Scientiﬁc, Shi-
pley,UnitedKingdom)containing85%N2,10%CO2,and5%O2.Unless
otherwisestated,C.jejunistrainsweregrownonbloodagarplatesfor24h
prior to use in experiments. Kanamycin was added as required at the
concentration of 50 g/ml.
Isolation of C. jejuni OMVs and TEM. OMVs were isolated as de-
scribedpreviously(49).C.jejunicellsfroma24-hplatewereresuspended
in 1 ml Brucella broth and inoculated into 100 ml Brucella broth to an
optical density at 600 nm (OD600) of 0.1. Cultures were grown for 14 h to
mid-log phase and then centrifuged at 10,000  g for 15 min, and the
resulting supernatant was ﬁltered through a 0.22-m membrane (Milli-
pore, Watford, United Kingdom). The ﬁltrate was concentrated to 2 ml
usinganUltra-4centrifugalﬁlterunitwithanominal10-kDacutoff(Mil-
lipore).Theconcentratedﬁltratewasultracentrifugedat150,000gfor3
hat4°CusingaTLS55rotor(BeckmanInstruments,PaloAlto,CA).The
absence of viable bacteria was conﬁrmed by plating OMV samples on
blood agar plates and incubating under both microaerobic and aerobic
conditions for 48 h. All isolation steps were carried out at 4°C, and the
resulting OMV pellet was resuspended in phosphate-buffered saline
(PBS) or 50 mM HEPES buffer (pH 7.4) and stored at 20°C. Approxi-
mately 200 g OMVs by protein content was isolated from 100 ml of
culture supernatant, determined by bicinchoninic acid (BCA) assay
(Thermo Fisher Scientiﬁc, Loughborough, United Kingdom). The
amounts of OMVs used in subsequent experiments are always quantiﬁed
by protein amount. For subsequent experiments, OMVs were pretreated
with either proteinase K (100 g/ml for 60 min at 37°C) or polymyxin B
(100g/mlfor30minatroomtemperature),oralternatively,OMVswere
heat treated (100°C for 20 min). For transmission electron microscopy
(TEM), C. jejuni OMVs were ﬁxed, dehydrated, and embedded in Epon
(38). Samples were examined using a Jeol 1200EX transmission electron
microscope at 80 kV (Welwyn Garden City, United Kingdom).
Liquidchromatography-electrosprayionizationtandemmassspec-
trometry (LC-ESI-MS/MS). Three biological replicates of 25 g OMVs
were separated by 12% (wt/vol) sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) (Invitrogen, Paisley, United Kingdom)
and then stained with Coomassie brilliant blue. Each stained gel lane was
excised and sliced horizontally from top to bottom to yield a series of 28
equal gel slices 2.5 mm deep. Each of the resulting gel slices was subjected
tostandardin-geldestaining,reduction,alkylation,andtrypsinolysispro-
cedures (66). Digests were transferred to high-performance LC (HPLC)
samplevialsandstoredat4°CuntilrequiredforLC-ESI-MS/MSanalysis.
LC was performed using an Ultimate 3000 nano-HPLC system (Dionex,
Camberley, United Kingdom) comprising a WPS-3000 well-plate micro-
auto-sampler, an FLM-3000 ﬂow manager and column compartment, a
UVD-3000UVdetector,anLPG-3600dual-gradientmicropump,andan
SRD-3600 solvent rack controlled by Chromeleon chromatography soft-
ware. A micropump ﬂow rate of 246 l/min
1 was used in combination
with a cap-ﬂow splitter cartridge, affording a ﬂow split of 1/82 and a ﬁnal
ﬂow rate of 3 l/min
1 through a 5-cm by 200-m ID monolithic re-
versed-phase column (Dionex) maintained at 50°C. Samples of 4 l were
applied to the column by direct injection. Peptides were eluted by the
application of a 15-min linear gradient from 8 to 45% solvent B (80%
[vol/vol] acetonitrile, 0.1% [vol/vol] formic acid) and directed through a
3-nlUVdetectorﬂowcell.LCwasinterfaceddirectlywithathree-dimen-
sional(3-D)high-capacityiontrapmassspectrometer(EsquireHCTplus;
Bruker Daltonics, Coventry, United Kingdom) via a low-volume (50 l/
min maximum) stainless steel nebulizer (Agilent, Wokingham, United
Kingdom)andESI.ParametersforMS/MSanalysisweresetaspreviously
described (5).
Database mining. Deconvoluted MS/MS data in mgf (Mascot Ge-
neric) format were imported into ProteinScape V2.1 (Bruker Daltronics)
proteomics data analysis software for downstream data mining of a cog-
nate C. jejuni 11168 genomic database utilizing the Mascot V2.2 (Matrix
Science, London, United Kingdom) search algorithm. The protein con-
tent of individual gel slices was established using the “protein search”
feature of ProteinScape, while separate compilations of the proteins con-
Elmi et al.
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 tained in all 28 gel slices of each of the three biological replicates were
produced using the “protein extractor” feature of the software. Mascot
search parameters were set in accordance with published guidelines (71),
and to this end, the ﬁxed and variable modiﬁcations selected were carb-
amidomethyl (C) and oxidation (M), respectively, and mass tolerance
values for MS and MS/MS were set at 1.5 Da and 0.5 Da, respectively.
Molecularweightsearch(MOWSE)scoresattainedforindividualprotein
identiﬁcationswereinspectedmanuallyandconsideredsigniﬁcantonlyif
(i) two peptides were matched for each protein and (ii) each peptide
containedanunbroken“b”or“y”ionseriesofaminimumoffouramino
acid residues.
SDS-PAGEandWesternblotanalysis.PuriﬁedC.jejuniOMVswere
mixed with Laemmli sample buffer (1:1) and separated by SDS-PAGE
(NuPage Novex Bis-Tris 4-12%; Invitrogen). Brieﬂy, 20 g of each OMV
sample was added to 2 Laemmli buffer and boiled for 10 min prior to
electrophoresis. Gels were stained with Coomassie brilliant blue stain or
blotted onto Immun-Blot polyvinylidene diﬂuoride (PVDF) membranes
(GE Healthcare, Chalfont St Giles, United Kingdom). For Western blots,
the separated proteins were transferred onto nitrocellulose membranes
(GE Healthcare) using the Mini Trans-Blot system (GE Healthcare). The
membrane was blocked with 10% (wt/vol) nonfat dried milk and incu-
batedovernightat4°C.Followingincubation,themembranewaswashed
threetimesandincubatedwithananti-Peb3antibody(1:2,000dilutionin
10% [wt/vol] nonfat dried milk), followed by1ho fincubation at room
temperature with a 1:10,000 dilution of anti-rabbit horseradish peroxi-
dase-conjugated secondary antibody (Sigma-Aldrich, Poole, United
Kingdom).TheblotswerevisualizedwithECLWesternblottingdetection
reagent(GEHealthcare).Forsoybeanagglutinin(SBA)lectinblotting,the
PVDFmembranewasblockedwith0.5%(vol/vol)Tween20inPBSfor30
min at room temperature and probed with 5 g of peroxidase-labeled
SBA (Sigma-Aldrich) for 1 h. The membrane was then washed with 0.5%
(vol/vol) Tween 20 in PBS and subjected to detection using the DAB
peroxidase substrate kit (Vector Laboratories, Peterborough, United
Kingdom).
Cell lines, media, and culture conditions. The human Caco-2 colon
adenocarcinoma cells and human T84 colon cancer epithelial cells were
obtained from the National Type Culture Collection. Caco-2 cells were
maintained at subconﬂuence in Dulbecco’s modiﬁed Eagle medium
(DMEM)with10%(vol/vol)heat-inactivatedfetalcalfserum(FCS)sup-
plemented with 1% (wt/vol) nonessential amino acids and 1% (wt/vol)
penicillin-streptomycin(Sigma-Aldrich)at37°Cina5%CO2humidiﬁed
atmosphere. T84 cells were maintained under the same conditions in
DMEM/F-12 (Invitrogen) supplemented with 10% (vol/vol) FCS, 1%
(wt/vol)nonessentialaminoacids,and1%(wt/vol)penicillin-streptomy-
cin. Cells were split around 80 to 90% conﬂuence and seeded at 5  10
5
cells per well into 24-well tissue culture plates (Corning Glass Works,
Corning, Netherlands) using 1-ml volumes of cell culture medium per
well. Medium was replenished every 2 days. For enzyme-linked immu-
nosorbentassays(ELISAs),themediumfromT84cellswasremoved,and
the monolayers were washed twice with PBS and then maintained in an-
tibiotic-free, serum-free DMEM/F-12 medium.
Cytotoxicity detection assay. The ability of OMVs isolated from C.
jejuni wild-type strain 11168H to induce cell damage was assessed using
the CytoTox 96 nonradioactive cytotoxicity assay (Promega, Southamp-
ton,UnitedKingdom).Brieﬂy,7dayspriortoinfection,Caco-2cellswere
seeded into 24-well plates, grown to conﬂuence, and challenged with 100
g of 11168H OMVs, proteinase K-treated OMVs, or polymyxin
B-treated OMVs. After coincubation at 37°C for 24 h, cell supernatants
were analyzed for the release of lactate dehydrogenase (LDH). Nonchal-
lengedcellsrepresentedthe0%cytotoxicitynegativecontrol.Totallysisof
cells following treatment with 1% (vol/vol) Triton X-100 represented the
100% cytotoxicity positive control.
Coincubation of C. jejuni OMVs with intestinal epithelial cell lines
and analysis of proinﬂammatory cytokines levels by ELISA. T84 cells
wereinfectedwithliveC.jejuniwild-typestrain11168HorcdtAmutantat
amultiplicityofinfection(MOI)of100:1orcoculturedwith100gor10
g of 11168H OMVs or cdtA mutant OMVs or proteinase K-treated or
polymyxin B-treated 11168H OMVs for 24 h. The levels of IL-8, IL-6,
tumornecrosisfactoralpha(TNF-),andhumanbeta-defensin-3(hBD)
secretion were assessed using a commercially available sandwich ELISA
kit according to the manufacturer’s instructions (Peprotech, London,
United Kingdom). Detection was performed using a Dynex MRX II 96-
well plate reader at an absorbance of 405 nm (A405) and analyzed using
Revelation software (Dynex).
Pretreatment of T84 cells with methyl--cyclodextrin treatment to
produce cholesterol depletion prior to coculture with C. jejuni OMVs.
To evaluate the role of cholesterol-rich membrane rafts in C. jejuni OMV
interactions with host cells, T84 cells were treated with 10 mM methyl--
cyclodextrin(MCD)(Sigma-Aldrich),acholesterol-depletingagent,for
1 h at 37°C before cells were washed twice with 1 ml of PBS. Following
cholesterol depletion, T84 cells were infected with the live C. jejuni
11168H wild-type strain at an MOI of 100:1 or cocultured with 100g C.
jejuni 11168H OMVs in 1% (vol/vol) serum-containing growth medium
at 37°C for the indicated periods.
Galleria mellonella model of C. jejuni infection. G. mellonella larvae
were obtained from LiveFoods Direct (Shefﬁeld, United Kingdom) and
kept on wood chips at 16°C. Experiments were performed with slight
modiﬁcations from the original published method (13) as described pre-
viously (26). Brieﬂy, 5 go r0 . 5g of 11168H OMVs or heat-treated
OMVswereinjectedintotherightforemostlegoftheG.mellonellalarvae
by microinjection (Hamilton, Switzerland). As a positive control, larvae
were injected with a 10-l inoculum of a 24-h C. jejuni 11168H culture
dilutedtoanOD600of0.1,givinganinfectiousdoseofapproximately10
6
CFU(26).Foreachexperiment,10G.mellonellalarvaewereinfected,and
the experiments (for which larvae of the same approximate weight were
chosen) were repeated three times. Larvae were incubated at 37°C, with
survival recorded at 24-h intervals for 72 h.
Statistical analysis. All experiments represent at least three biological
replicates, with each experiment performed in triplicate. All data were
analyzed using Prism statistical software (Version 5; GraphPad Software,
SanDiego,CA).Valueswereexpressedasmeansstandarderrorsofthe
means (SEM). Variables were compared for signiﬁcance using two-way
analysis of variance (ANOVA) and the Bonferroni test, with one asterisk
(*) indicating a P value between 0.01 and 0.05, two asterisks (**) indicat-
ing a P value between 0.001 and 0.01, and three asterisks (***) indicating
a P value of 0.001.
RESULTS
Campylobacterjejuni11168HproducespleiomorphicOMVsof
variable sizes. Previously it was demonstrated that the C. jejuni
wild-type strain 81-176 produces distinct OMVs of various sizes
and shapes (49). OMVs were isolated from the C. jejuni wild-type
strain 11168H using a similar protocol (49). TEM analysis of pu-
riﬁed OMVs revealed the presence of typical spherical vesicles
withapleiomorphicbilayer(Fig.1A).TheseOMVswerefoundto
differ in size from 10 nm to 250 nm. The apparent density of the
isolated OMVs was mixed, suggesting variation in the contents
among individual OMVs. To eliminate the possibility of OMVs
arising from dead cells, bacterial viability assays were performed
on exponential-growth-phase cultures prior to vesicle isolation.
The results indicated that 	99% of cells prior to OMV isolation
were viable (data not shown). OMVs isolated from wild-type
strain 81-176 displayed the same characteristics (Fig. 1B).
Proteomic analysis of C. jejuni 11168H OMVs. The presence
of virulence-associated proteins in bacterial OMVs is widespread
(19). The major protein components of triplicate samples of C.
jejuni 11168H OMVs were analyzed using one-dimensional (1D)
SDS-PAGE followed by LC-ESI-MS/MS. Proteomic analysis re-
producibly identiﬁed 151 proteins in at least two of the three bio-
Campylobacter jejuni Outer Membrane Vesicles
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 logical replicate samples. The proportions of proteins from each
cluster of orthologous groups (COG) categorization (70) is pre-
sented in Fig. 2. Proteins with unknown function represented the
largest proportion (26%). Sixteen further COG categories were
represented in the OMV proteome, a ﬁnding that is in line with
OMV content in other pathogenic bacteria. Many membrane-
associatedproteinsweredetected(seeTableS1inthesupplemen-
tal material) including several characterized lipoproteins and
outer membrane proteins. The presence of a large number of
periplasmic and cytoplasmic proteins supports the observations
that OMV composition derives from multiple bacterial compart-
ments and not solely from the outer membrane. The presence of
previously identiﬁed virulence factors such as CDT was con-
ﬁrmed, and 16 C. jejuni glycoproteins (65) were also identiﬁed in
OMVs. LipoP (http://www.cbs.dtu.dk/services/LipoP/) was used
to predict signal peptides and lipoprotein signal peptides (36).
N-linkedglycoproteinsareassociatedwithC.jejuni11168H
OMVs. All C. jejuni genomes sequenced to date encode an N-
linkedproteinglycosylation(Pgl)pathway(69).N-linkedprotein
glycosylationoccursintheperiplasm,wheremanyoftheproteins
associated with OMVs are also localized. N-linked glycosylation
may be involved in the evasion of the host immune response, as
mutation of pgl genes that encode the glycan biosynthesis system
resultsinchangesinimmunoreactivity(68).Proteomicanalysisof
11168H OMVs identiﬁed 16 proteins that have been shown to be
C. jejuni glycoproteins (65). To conﬁrm the presence of N-linked
glycoproteins associated with OMVs, 11168H OMVs were sepa-
ratedby1DSDS-PAGEandprobedwithSBAlectintoidentifythe
C. jejuni heptasaccharide glycan that has a terminal GalNac resi-
duespeciﬁcallyrecognizedbySBAlectin(51).SBAlectinboundto
multiple bands (Fig. 3) indicating that 11168H OMVs contain
numerous glycoproteins. A C. jejuni 11168H pglB mutant deﬁ-
cient for N-linked glycosylation was used as a control. SBA lectin
did not bind to OMVs isolated from the 11168H pglB mutant,
which lacks the oligosaccharyltransferase PglB to attach the hep-
tasaccharideglycantoproteinsintheperiplasm.Thisistheﬁrst
indirect evidence indicating that C. jejuni OMVs may deliver
antigenic N-linked glycoproteins to host cells. One of the 16
N-linked glycoproteins associated with 11168H OMVs identi-
ﬁed by the proteomic analysis was Peb3. Peb3 was ﬁrst identi-
ﬁedasoneoffourmajorantigenicC.jejuniproteinsthatcross-
reacted with antiserum from convalescent patients (61), later
identiﬁed as a glycoprotein (50) and more recently as a trans-
port protein involved with the utilization of phosphate-con-
taining molecules from the host (55). The association of Peb3
with C. jejuni 11168H wild-type and pglB and peb3 mutant
OMVswasinvestigatedbyimmunoblottingusingananti-Peb3
antibody and compared with whole-cell lysates. This indicated
the presence of both glycosylated and unglycosylated Peb3 as-
sociated with 11168H OMVs (Fig. 4). A reduced amount of
unglycosylated Peb3 and no glycosylated Peb3 were detected
with pglB mutant OMVs compared to wild-type OMVs. Peb3
was undetectable in peb3 mutant OMVs. In addition, analysis
of wild-type strain 11168H outer membrane and periplasmic
fractions indicated that Peb3 was located within the periplasm
and not associated with the outer membrane (Fig. 4).
C. jejuni 11168H OMVs are cytotoxic to Caco-2 intestinal
epithelial cells. The cytotoxicity of OMVs on Caco-2 cells was
measured by quantifying the release of cytosolic lactate dehydro-
genase(LDH)asameasureofcelldamage.Liveandheat-killedC.
jejuni 11168H cells (MOI, 100:1), untreated 11168H OMVs (100
g by protein content), and proteinase K- or polymyxin B-pre-
treated 11168H OMVs (100 g) were coincubated with Caco-2
cells for 24 h. Thecytotoxic effect of untreated 11168H OMVs (100
g) was not statistically different from the cytotoxic effect of live
wild-type 11168H cells (MOI, 100:1) over 24 h, while heat-killed
11168H cells (MOI, 100:1) showed a statistically signiﬁcant decrease
in cytotoxicity (P  0.05) (Fig. 5). The cytotoxicity of OMVs pre-
treatedwitheitherproteinaseKorpolymyxinBwassimilartothatof
untreatedOMVsandwasnotstatisticallydifferentfromthecytotoxic
effect of live wild-type 11168H cells (MOI, 100:1) over 24 h.
C. jejuni 11168H OMVs induced an IL-8, IL-6, TNF-, and
hBD-3responsefromT84intestinalepithelialcells.C.jejuniin-
FIG1 TransmissionelectronmicrographsofnegativelystainedC.jejuniouter
membranevesicles(OMVs).C.jejuniwild-typestrain11168HOMVs(A)and
81-176 OMVs (B) with intact bilayer membranes. OMVs have an irregular
spherical shape and are not uniform in size. Arrows indicate differences in the
apparentdensityoftheisolatedOMVs.ThediametersofOMVsrangefrom10
to 250 nm (scale bar, 500 nm).
FIG 2 Major protein functional categories (COGs) identiﬁed in C. jejuni
11168H outer membrane vesicles following proteomic analysis.
Elmi et al.
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 teractions with IECs modulate both the innate and the adaptive
immune responses (14, 53, 63). However, the role of C. jejuni
OMVs in inducing such host responses has not been reported.
IEC-derivedIL-8,IL-6,TNF-,andhBD-3arewell-characterized
markersdenotinganearlyhostresponseagainstC.jejuni(56).T84
cellswerecoincubatedwithC.jejuni11168HOMVs(10gor100
g) for 24 h, and the levels of IL-8, IL-6, TNF-, and hBD-3
secreted were measured by ELISA (Fig. 6A to D). The levels of
IL-8, IL-6, TNF-, and hBD-3 induced by 11168H OMVs (100
g) were signiﬁcantly increased and similar to those of live C.
jejuni wild-type strain 11168H (MOI, 100:1). A reduced but still
signiﬁcantlevelofIL-8wasinducedby10gOMVscomparedto
100gOMVs(Fig.6A).ThehostimmuneresponseinducedbyC.
jejuniOMVswasnotsigniﬁcantlyreducedfollowingpretreatment
of OMVs with either proteinase K or polymyxin B (Fig. 6E). To-
gether, these data demonstrate that C. jejuni OMVs alone can
induce production of signiﬁcant levels of IL-8, IL-6, TNF-, and
hBD-3 from T84 cells, independently of live bacterial cells.
MCD can partially block the innate immune response in-
ducedbyC.jejuni11168HOMVs.Thedetailedmechanismsand
host cell receptor(s) leading to the signaling cascade(s) that result
in the host response to coincubation with bacterial OMVs have
not yet been identiﬁed. OMV-induced signaling has been shown
to occur via the speciﬁc glycolipid and cholesterol-enriched do-
mains in the cell plasma membrane termed “lipid rafts” (10, 17,
23, 25, 32, 37). To investigate the role of lipid rafts in the host
cellularresponsetoC.jejuniOMVs,T84IECsweretreatedwith10
mM methyl-beta-cyclodextrin (MCD), a lipid-raft-disrupting
agent, for 1 h before coincubation with C. jejuni 11168H OMVs
for 24 h. This pretreatment of T84 cells with MCD resulted in a
signiﬁcant (P  0.05) inhibition of the OMV-stimulated induc-
tion of IL-8 (Fig. 7, left) and hBD3 (Fig. 7, right). Live C. jejuni
wild-typestrain11168HcellsstimulatedT84cellspretreatedwith
MCD showed a more signiﬁcant reduction in IL-8 induction
(Fig. 7, left; P  0.01) and hBD3 (Fig. 7, right; P  0.001), consis-
tent with published data (37, 72). These results indicate a role for
membrane lipid rafts as important determinants of C. jejuni
FIG 3 N-linked glycoproteins are associated with C. jejuni 11168H outer membrane vesicles (OMVs). C. jejuni wild-type strain 11168H and pglB mutant
whole-cell lysates (A) or OMVs (B) separated by SDS-PAGE and stained with Coomassie brilliant blue stain. Corresponding SBA lectin binding to whole-cell
lysates(C)orOMVs(D)toprobefortheN-linkedglycanattachedtoC.jejuniproteinsbytheoligosaccharyltransferasePglBinthebacterialperiplasm.Molecular
mass sizes (kDa) are indicated.
FIG4 ImmunoblotanalysisofpuriﬁedC.jejuniwild-typestrain11168H,pglB
mutant,andpeb3mutantoutermembranevesicles(OMVs)withananti-Peb3
antibody. Puriﬁed OMVs (omvs) were separated by SDS-PAGE followed by
immunoblotting with an anti-Peb3 antibody and compared with wild-type
strain11168H,pglBmutant,andpeb3mutantwhole-celllysates(wcl)andalso
puriﬁed outer membrane (om) and periplasmic (periplasm) fractions from
the wild-type strain 11168H.
FIG 5 Cytotoxic effect of C. jejuni 11168H outer membrane vesicles (OMVs)
onCaco-2intestinalepithelialcells.LiveC.jejuni11168H(MOI,100:1),heat-
killed C. jejuni 11168H (MOI, 100:1), untreated 11168H OMVs (100 g), or
11168H OMVs (100 g) pretreated with either proteinase K (PK) or poly-
myxin B were coincubated with Caco-2 cells for 24 h. The cytotoxic effect on
the Caco-2 cells was measured by quantifying the release of cytosolic lactate
dehydrogenase (LDH) as a measure of cell damage. Nonchallenged Caco-2
cells represented 0% cytotoxicity (Uninfected), and total lysis of Caco-2 cells
following treatment with 1% (vol/vol) Triton X-100 represented 100% cyto-
toxicity(Positivecontrol).*,P0.05;ns,nosigniﬁcantdifferenceincytotox-
icity compared to live 11168H cells.
Campylobacter jejuni Outer Membrane Vesicles
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 OMV-mediated signal transduction. However, the exact mecha-
nism of MCD-induced inhibition of C. jejuni OMV interactions
withhostcellsremainsunknown.MCDdidnotaffectcellinteg-
rity or viability at the concentration used as determined using
inverted microscopy and the cytotoxicity assay (data not shown).
C. jejuni OMVs induced IL-8 from T84 intestinal epithelial
cells via a CDT-independent mechanism. C. jejuni induction of
IL-8 from IECs has been shown to be both CDT dependent and
CDT independent (30). The mechanism of IL-8 induction by C.
jejuni 11168H OMVs was investigated further, using OMVs iso-
lated from a 11168H cdtA mutant (Fig. 8). The levels of IL-8 in-
ducedbythelivecdtAmutantwerenotsigniﬁcantlyreducedcom-
pared to those induced by live wild-type strain 11168H (MOI,
100:1).ThelevelsofIL-8inducedbycdtAmutantOMVswerealso
not signiﬁcantly reduced compared to those induced by 11168H
OMVs,indicatingthatinductionofIL-8byC.jejuniOMVsoccurs
via a CDT-independent mechanism.
G. mellonella larvae exhibit decreased survival after chal-
lengewithC.jejuni11168HOMVs.ThecytotoxicpotentialofC.
jejuniOMVswasfurtherinvestigatedusingtheGalleriamellonella
larvae model of infection. This invertebrate model has been used
to assess the virulence of numerous human bacterial pathogens,
including C. jejuni (13). The larvae do not have an adaptive im-
munesystembuthavepotentinnateimmunityandareresistantto
microbial infections via cellular and humoral defenses. G. mello-
nella larvae were injected with either C. jejuni wild-type strain
11168HorthecdtAmutantstrain(10
6CFU)orOMVs(5gor0.5
g). At 24 h postinfection, the mortality of G. mellonella larvae
challenged with 11168H OMVs (5 g) was signiﬁcantly increased
(P  0.001) and was similar to that of larvae infected with the live
wild-type strain 11168H (P  0.001) (Fig. 9). Larvae challenged
with 11168H OMVs (0.5 g) also showed a signiﬁcant increase in
mortality (P  0.05) but showed reduced mortality compared to
larvae challenged with 11168H OMVs (5 g) (Fig. 9). No further
FIG 6 C. jejuni 11168H outer membrane vesicles (OMVs) induce an innate immune response from T84 intestinal epithelial cells (IECs). (A to D) T84 IEC
responses to 24 h of coincubation with C. jejuni wild-type strain 11168H (MOI, 100:1) or OMVs (100 go r1 0g) were assessed. Levels of IL-8, IL-6, TNF-,
and hBD-3 secreted during C. jejuni OMV interactions with T84 cells were quantiﬁed using a human IL-8 ELISA (A), IL-6 ELISA (B), TNF- ELISA (C), or
hBD-3ELISA(D).(E)T84IECresponsesto24hofcoincubationwithC.jejuni11168H(MOI,100:1),untreated11168HOMVs(100g),or11168HOMVs(100
g) pretreated with either proteinase K (PK) or polymyxin B. Levels of IL-8 secreted were quantiﬁed using a human IL-8 ELISA. *, P  0.05; **, P  0.01;
***, P  0.001; ns, no signiﬁcant difference.
Elmi et al.
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 mortality was observed at either 48 h or 72 h postinfection (data
not shown). Larvae either infected with the cdtA mutant or chal-
lenged with OMVs isolated from the cdtA mutant showed no sig-
niﬁcant difference in mortality compared to those infected with
thewild-typestrainor11168HOMVs,respectively(Fig.9).How-
ever, no mortality was observed with G. mellonella larvae infected
with heat-treated 11168H OMVs (5 go r0 . 5g).
DISCUSSION
One of the many conundrums regarding C. jejuni pathogenesis is
the lack of classical virulence-associated bacterial secretion sys-
tems possessed by other enteric pathogens. As such, the mecha-
nisms used by C. jejuni to deliver virulence factors into host cells
are still unclear and have become a matter of conjecture (74).
OMVs are increasingly recognized as key determinants for bacte-
rial virulence (47) and play a major role in host-pathogen inter-
actions, including the trafﬁcking and eventual release of diverse
virulencefactorsfrommanypathogenicbacteria(19).Recently,it
was shown that the C. jejuni wild-type strain 81-176 produces
OMVs that contain biologically active CDT (49). This indicated
that C. jejuni might utilize OMVs as a delivery system during
pathogenesis.Inthisstudy,weusedproteomictechniquestoiden-
tify proteins associated with C. jejuni 11168H OMVs and investi-
gated the effects of the coordinated delivery to human IECs of C.
jejuni virulence factors via OMVs in eliciting inﬂammatory and
cytotoxic responses.
In this study, OMVs isolated from both C. jejuni wild-type
strains 11168H and 81-176 varied in size from 10 to 250 nm.
Previously,itwasreportedthatOMVsisolatedfromstrain81-176
varied in size from 10 to 50 nm (49). The isolation of OMVs of
different sizes may be explained by the use of a different growth
temperature (42°C) and different medium (Muller-Hinton bi-
phasic agar/broth) in the previous study (49). Indeed, the size
range of OMVs isolated in this study is consistent with that of
OMVsisolatedfromotherGram-negativebacteria(16).Variation
inthesize,shape,andelectrondensityofC.jejuniOMVssuggests
thattheremaybedifferentialsortingofOMVcargoproteins,asis
the case for P. gingivalis OMVs (28).
Proteome analysis of OMVs from C. jejuni 11168H identiﬁed
atleast151proteinsderivedmainlyfromtheoutermembraneand
periplasm but also associated with the inner membrane and cyto-
plasm. The virulence-associated proteins identiﬁed included all
threecomponentsofCDT(CdtA,CdtB,andCdtC),theﬁbronec-
tin binding proteins CadF and FlpA, and the HtrA and Cj0511
proteases, as well as 16 N-linked glycoproteins, including the ma-
jor antigenic protein Peb3. Apart from CDT, this is the ﬁrst dem-
onstration that virulence-associated C. jejuni proteins are deliv-
ered via OMVs. None of the three characterized secreted Cia
FIG7 PreincubationofT84cellswithmethyl-beta-cyclodextrin(MCD)can
partiallyblocktheinnateimmuneresponseinducedbyC.jejuni11168Houter
membranevesicles(OMVs).T84intestinalepithelialcellswerepretreatedwith
10 mM MCD for 1 h and then coincubated with C. jejuni wild-type strain
11168H (MOI, 100:1) or OMVs (100 g). Levels of IL-8 and hBD-3 secreted
were quantiﬁed using a human IL-8 ELISA (left) or hBD-3 ELISA (right) and
presented as the percentage of IL-8 induced by C. jejuni wild-type strain
11168H (MOI, 100:1). *, P  0.05; **, P  0.01; ***, P  0.001.
FIG 8 C. jejuni outer membrane vesicles (OMVs) induce IL-8 from T84 in-
testinalepithelialcellsviaaCDT-independentmechanism.T84IECresponses
to24hofcoincubationwithC.jejuniwild-typestrain11168Hor11168HcdtA
mutant (each at a MOI of 100:1) or with 11168H OMVs or 11168H cdtA
mutantOMVs(eachat100gand10g)wereassessed.LevelsofIL-8secreted
were quantiﬁed using a human IL-8 ELISA. ns, no signiﬁcant difference.
FIG 9 Effect of C. jejuni outer membrane vesicles (OMVs) in the Galleria
mellonella infection model. G. mellonella larvae were injected with a 10-l
inoculum of either C. jejuni wild-type strain 11168H (10
6 CFU) or 11168H
OMVs (5 go r0 . 5g) or heat-treated 11168H OMVs (5 go r0 . 5g) by
microinjection in the right foremost leg. Larvae were incubated at 37°C, with
survival and appearance recorded after 24 h. PBS and no-injection controls
were used. For each experiment, 10 G. mellonella larvae were infected, and
experiments were repeated in triplicate. *, P  0.05; ***, P  0.001.
Campylobacter jejuni Outer Membrane Vesicles
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 proteins CiaB, CiaC, and CiaI (11, 15, 42) were found to be asso-
ciated with C. jejuni OMVs, suggesting that OMVs are not the
mechanism by which these virulence factors are secreted. The
identiﬁcation of a large number of N-linked glycoproteins associ-
ated with C. jejuni OMVs is particularly signiﬁcant. The role of
N-linked glycosylation in the biology of C. jejuni is still not fully
understood. N-linked glycosylation may be involved in the eva-
sion of the host immune response, as mutation of pgl genes that
encodetheglycanbiosynthesissystemresultsinchangesinimmu-
noreactivity (68). However, as most N-linked glycoproteins are
not predicted to be surface exposed but rather located in the
periplasm (75), it has been unclear why posttranslational modiﬁ-
cation of these proteins should enhance immune evasion. The
identiﬁcation of N-linked glycoproteins associated with C. jejuni
OMVs indicates a mechanism by which these periplasm-located
proteins may be delivered into human IECs to which the human
immune system responds. The fact that Peb3 appears to be local-
izedintheperiplasmcoupledwiththereductionintheamountof
Peb3 in pglB mutant OMVs compared to wild-type OMVs sug-
gests that N-linked glycosylation may also play a role in OMV
cargoselection.Thisissupportedbythepreviousobservationthat
when the C. jejuni N-linked glycosylation pathway is functionally
transferred into E. coli, N-linked glycoproteins are identiﬁed
within E. coli OMVs (20).
ManyOMV-associatedtoxinshavebeenidentiﬁed,andOMVs
havebeenshowntodeliveractivetoxinstohostcellsfromavariety
of enteric pathogens, including ETEC, Shiga toxin-producing E.
coli, and Helicobacter pylori (19). Virtually all the CDT secreted
from C. jejuni wild-type strain 81-176 was found to be OMV as-
sociated, and coculture of 81-176 OMVs with the HCT8 human
ileocecum carcinoma cell line induced a distinct cell enlargement
and caused cell cycle arrest associated with the cytolethal distend-
ing effects of C. jejuni CDT (49). In this study, C. jejuni 11168H
OMVs were shown to be cytotoxic to Caco-2 cells after a 24-h
exposure, as measured by the presence of extracellular LDH, sug-
gesting a role for other cytotoxic C. jejuni factors in addition to
CDT, such as bacterial exotoxic proteases that can damage extra-
cellular structures, as the primary effect of CDT is eukaryotic cell
cycle arrest at the G2/M stage, which results in a cessation of cell
division rather than cell lysis (49). The two serine proteases iden-
tiﬁed as associated with C. jejuni 11168H OMVs by proteomic
analysiswereHtrA(4,9)andCj0511.Furtherstudiesarerequired
to establish whether this is a result of OMV-induced reduction in
host cell membrane integrity or actual host cell lysis, though it is
tempting to speculate that C. jejuni OMVs could modulate
changes in human IEC membranes that enhance bacterial inva-
sion.
Bacterial OMVs have been shown to be activators of the host
innate and acquired immune response pathways (19). The effect
of OMV-associated virulence factors can modulate the host im-
muneresponseresultinginpromotionofimmune/inﬂammation-
mediated damage or stimulation of clearance of the pathogen
(19).AproinﬂammatoryresponsetoOMVshasbeenobservedfor
severalbacterialspecies,includingH.pylori(33)andP.aeruginosa
(6). Human IECs produce the proinﬂammatory cytokines IL-6
(22) and TNF- (3) as well as the proinﬂammatory chemokine
IL-8 (53) in response to C. jejuni infection in vitro. hBDs are an-
timicrobial peptides involved in innate immune defenses against
pathogenic bacteria (59). Infection with C. jejuni leads to in-
creased transcription, translation, and secretion of hBD-2 and
hBD-3 from Caco-2 and HT-29 human IECs (77). This study is
the ﬁrst to show that C. jejuni OMVs act as initiators of the host
immune response, inducing IL-8, IL-6, TNF-, and hBD-3. The
induction of IL-8 was also shown to be dependent on the concen-
tration of C. jejuni 11168H OMVs incubated with T84 cells. The
observation that OMVs pretreated with proteinase K show no
reduction in the ability to induce both IL-8 and hBD-3 indicates
that the C. jejuni virulence factors involved in the induction of
these host responses are intravesicular components of OMVs,
sinceproteinaseKwilldegradeproteinsexternallyassociatedwith
OMVsbutnotthosewithinthelumenoftheOMVs(10).LOSare
a constituent of C. jejuni OMVs, so this could play a role in the
induction of the innate immune response. The observation that
OMVs pretreated with polymyxin B show no reduction in the
ability to induce IL-8 indicates that C. jejuni LOS is not a major
determinantinthehostresponsetoOMVsobservedinthisstudy.
LOS activates proinﬂammatory cytokine and chemokines such as
IL-8 through the signaling of Toll-like receptor 4 (TLR4) ex-
pressedonthesurfaceofhumanIECs.However,T84cellsexpress
only low levels of TLR4 (1), so a role for OMV-associated LOS in
inducing the innate immune response should not be dismissed.
One result of the proinﬂammatory response is the alteration of
epithelial barrier function (64), and the induction of such a host
cell response by C. jejuni OMVs may be a cause of the loss of host
cell membrane integrity indicated by the cytotoxicity assay.
OMVs have been shown to deliver bacterial virulence factors
intohostcellsbyfusionwiththehostcellplasmamembraneorvia
receptor-mediatedendocyticpathways(19,47).BindingofOMVs
to lipid rafts has been reported for a number of bacterial patho-
gens, including ETEC (40), H. pylori (37), and P. aeruginosa (10).
Disruption of the lipid rafts from the cell membranes of T84 cells
with the cholesterol-depleting agent MCD resulted in a reduc-
tion of the ability of C. jejuni OMVs to induce secretion of both
IL-8 and hBD-3, indicating that these cholesterol-enriched do-
mains may be similarly involved in the delivery of C. jejuni viru-
lence factors by OMVs into human IECs. However, C. jejuni
OMVs still induced secretion of both IL-8 and hBD-3 from
MCD-treated T84 cells, well above the levels observed in the
controls.Thiswouldsuggestthatotherpathwaysarealsoinvolved
in OMV delivery of bacterial virulence factors into host cells. The
identiﬁcation of the ﬁbronectin binding proteins CadF (44) and
FlpA(45)aswellasthemajorantigenicproteinPeb3(61)andthe
serine protease HtrA (4) associated with C. jejuni OMVs would
indicate further possible mechanisms for the adherence of OMVs
to human IECs, which could lead to internalization of OMVs by
receptor-mediated endocytosis.
In this study, the levels of IL-8 induced by live 11168H cdtA
mutantwerenotsigniﬁcantlyreducedcomparedtothoseinduced
bylivewild-typestrain11168H(MOI,100:1).Thisisinsupportof
the ﬁndings in a previous study that showed that 81-176 cdtA,
cdtB,andcdtCmutantsinduceIL-8fromINT407cellstoanextent
similartothatofthewild-typestrain(30).Inaddition,thelevelsof
IL-8 induced by cdtA OMVs were similar to those induced by
11168H OMVs (for both 100-g and 10-g amounts). Previ-
ously, membrane fractions isolated from 81-176 cdtA, cdtB, and
cdtC mutants have been shown not to induce IL-8 from INT407
cells, in contrast to those from the wild-type strain (29, 30), sug-
gesting a different activity for CDT within OMVs compared to
membrane-bound CDT. The data in the present study indicate
Elmi et al.
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 that induction of IL-8 by C. jejuni OMVs occurs via a CDT-inde-
pendent mechanism.
G. mellonella larvae have been reported to be susceptible to C.
jejuni infection as well as other enteric pathogens (12, 13). OMVs
from Xenorhabdus nematophila and Photorhabdus luminescens
have been shown to be cytotoxic both in tissue culture and to
insectlarvae(41).InoculationofG.mellonellalarvaewitheitherC.
jejuni 11168H or cdtA mutant OMVs resulted in killing of the
larvae to the same extent. The cytotoxicity of 11168H OMVs was
abolished by heat treatment, suggesting cytotoxicity is mediated
by proteins within the OMVs. This is the ﬁrst report of C. jejuni
OMVskillinglarvaeandisalsofurtherevidenceofthecytotoxicity
of C. jejuni OMVs, which occurs via a CDT-independent mecha-
nism.
In this study, we have demonstrated the importance of OMVs
as a delivery vehicle for C. jejuni virulence factors and highlighted
a number of effects on human IECs, including cytotoxicity and
inductionoftheinnateimmuneresponse,includingthesecretion
of IL-8 from T84 cells via a CDT-independent mechanism. The
identiﬁcation of N-linked glycoproteins associated with C. jejuni
OMVs indicates a mechanism for delivering these modiﬁed pro-
teins, which are usually located in the bacterial periplasm, into
host cells and could thus account for the reported immunogenic-
ity of these proteins. Further studies are required to elucidate the
role of the individual C. jejuni virulence factors secreted within
OMVs during pathogenesis and the modulation of the host cell
response to C. jejuni infection.
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